Brain natriuretic peptide: a potential indicator of cardiomyogenesis after autologous mesenchymal stem cell transplantation?
We observed in a pilot study that there was a transient elevation of brain natriuretic peptide (BNP) level shortly after the transplantation in the patient with ischemic heart failure, which is unexplainable by the simultaneous increase of the cardiac output and six-minute walk distance. Similar findings were observed in the phase I trial. We postulated on the basis of the finding of Fukuda in vitro that this transient elevation of BNP level against the improvement of cardiac function and exercise capacity might indicate cardiomyogenesis in patients after mesenchymal stem cell transplantation. Further study is warranted to verify the hypothesis.
Li
Nan
N
Wang
Jian-an
JA
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D008875:Middle Aged; D024510:Muscle Development; D032383:Myocytes, Cardiac / Q000502:physiology*; D020097:Natriuretic Peptide, Brain / Q000502:physiology*; D014182:Transplantation, Autologous; D020257:Ventricular Remodeling
D020097:Natriuretic Peptide, Brain